CCN2 and ovarian neoplasm: Enhanced YAP phosphorylation deactivates YAP, suppressing TEAD-mediated target genes such as connective tissue growth factor (CTGF) and CYR61 (Figure 7E), ultimately inhibiting cancer cell proliferation in vitro and reducing ovarian tumor growth in vivo.